https://doi.org/
Poster
NOT PEER REVIEWED
Download
metrics
VIEWS
638
 
downloads
123
CITE
How to cite this poster:
Detrait E, Laruelle M, Lamberty Y et al. Negative modulation of the synaptic vesicle protein (SV2A): a new pharmacological target for cognitive deficit associated with schizophrenia. F1000Posters 2014, 5:455 (poster)

Negative modulation of the synaptic vesicle protein (SV2A): a new pharmacological target for cognitive deficit associated with schizophrenia

Eric Detrait1, Marc Laruelle, Yves Lamberty, Karine Leclercq, Eric Jnoff, Martyn Wood, Michel Gillard, Emilie Jigorel, Henrik Klitgaard, Laurent Provins
Published 03 Jun 2014
Author Affiliations
  • Metrics
  • 638 Views
  • 123 Downloads
Browse by related subjects
Published 03 Jun 2014

Negative modulation of the synaptic vesicle protein (SV2A): a new pharmacological target for cognitive deficit associated with schizophrenia

[version 1; not peer reviewed]

Eric Detrait1, Marc Laruelle, Yves Lamberty, Karine Leclercq, Eric Jnoff, Martyn Wood, Michel Gillard, Emilie Jigorel, Henrik Klitgaard, Laurent Provins
Author Affiliations
1 UCB Biopharma, Belgium
Presented at
69th Society of Biological Psychiatry Annual Meeting 2014
Abstract
Competing Interests

Eric Detrait is an employee of UCB Biopharma.

Comments
0 Comments
 
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.